Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TYNI Trial
NCT05486468Phase 3Completed
- Sponsor
- Texas Retina Associates
- Start
- Oct 2022
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluocinolone in posterior uveitis, sponsored by Texas Retina Associates. Started Oct 2022; status: completed.
02
Drugs
fluocinolone
03
Conditions
posterior uveitis
Beyond the preview
Go deeper on NCT05486468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05486468.